Strain Information | |
|---|---|
| Image | |
| BRC No. | RBRC01361 |
| Type | Targeted Mutation |
| Species | Mus musculus |
| Strain name | B6.Cg-Trp53<tm1Sia>/Rbrc |
| Former Common name | C57BL-p53+/- |
| H-2 Haplotype | |
| ES Cell line | TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] |
| Background strain | C57BL/6NCrSlc |
| Appearance | black [a/a B/B C/C] |
| Strain development | 理化学研究所筑波研究所・相沢慎一。TT2 ES細胞(B6CBAF1由来)を用いて作出。京都大学放射線生物研究センター・丹羽大貫(C57BL/6背景、ICR背景およびC3H背景)、大阪大学大学院生命機能研究科・八木 健(DBA/2背景)、新潟大学大学院医歯学総合研究科・木南 凌(MSM背景)らによりコンジェニック育成。 |
| Strain description | p53 (Trp53) 遺伝子のノックアウトマウス。p53はアポトーシス、細胞周期、DNA修復機構に関与するガン抑制遺伝子。第2エクソンにhomologous recombinationによりneo遺伝子を挿入。ホモマウスは様々な部位でガンが発生する (3から6ヶ月齢頃までに) 。C57BL/6背景 (RBRC01361) 、ICR背景 (RBRC01348) 、C3H背景 (RBRC00107) 、DBA/2背景 (RBRC01518) およびMSM背景 (RBRC00815) があり。ガンを発症する前であればホモマウスも繁殖可能 (成績は低い) 。C57BL/6背景ではホモマウスのメスはほとんど生まれてこない (MSM背景もおそらく同様) 。 |
| Colony maintenance | Heterozygote x Wild-type [C57BL/6NCrSlc] |
| References | Enhanced proliferative potential in culture of cells from p53-deficient mice. T Tsukada, Y Tomooka, S Takai, Y Ueda, S Nishikawa, T Yagi, T Tokunaga, N Takeda, Y Suda, S Abe Oncogene, 8, 3313-3322 (1993). 7504233 |
Health Report | |
|---|---|
| Examination Date / Room / Rack | 2025/11/17Room:3-CRack:E囮検査 2025/09/08Room:3-CRack:E囮検査 2025/06/30Room:3-CRack:E囮検査 2025/04/21Room:3-CRack:E囮検査 2025/01/20Room:3-CRack:E囮検査 2024/10/21Room:3-CRack:E囮検査 2024/07/22Room:3-CRack:E囮検査 2024/04/22Room:3-CRack:E囮検査 |
Gene | |||||||
|---|---|---|---|---|---|---|---|
| Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
| Trp53 MGI:98834 | transformation related protein 53 | 11 | Trp53<tm1Sia> MGI:1926340 | targeted mutation 1, Shinichi Aizawa | more 20 Diseases | ||
| neo | neomycin resistance gene (E. coli) | 11 | herpes simplex virus thymidine kinase promoter (HSV tk promoter) | ||||
Phenotype | |
|---|---|
| Phenotype annotation from literatures by Mammalian phenotype ontology | |
| Detailed phenotype data | ![]() |
Ordering Information | |
|---|---|
| 供与核酸 | herpes simplex virus thymidine kinase promoter (HSV tk promoter), E. coli neo, HSV tk polyA, mouse p53 genomic DNA |
| Research application | Cancer Research Cell Biology Research Immunology and Inflammation Research Mouse Models for Human Disease |
| 提供条件 | 研究成果の公表にあたって寄託者の指定する文献を引用する。Oncogene, 8, 3313-3322 (1993). 研究成果の公表にあたっては当該変異マウスのAcc. No.『CDB 0001K』を記すこと。 (Acc. No.に関してはホームページ(https://large.riken.jp/distribution/mutant-list.html)をご覧下さい) 研究成果の公表にあたって発表論文をCDB変異マウス開発チーム mutant.bdr@riken.jp 迄連絡する事。 |
| Depositor | 丹羽 太貫(国立大学法人京都大学) |
| Strain Status | 凍結胚 凍結精子 |
| Strain Availability | 凍結胚より作出したマウスを2~4ヶ月以内に提供可能 凍結精子を1ヶ月以内に提供可能 凍結胚を1ヶ月以内に提供可能 |
| Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- Mouse of the Month Jun 2005 Genetic Background |
BRC mice in Publications |
|---|
Kanatsu-Shinohara M, Yamamoto T, Liu T, Nakayama KI, Shinohara T. Cdkn1c orchestrates a molecular network that regulates the euploidy of the male mouse germline stem cells. Development (2025) 39850012 |
Tokumasu R, Yasuhara R, Kang S, Funatsu T, Mishima K. Transcription factor FoxO1 regulates myoepithelial cell diversity and growth. Sci Rep 14(1) 1069(2024) 38212454 |
Liu X, Sato N, Yabushita T, Li J, Jia Y, Tamura M, Asada S, Fujino T, Fukushima T, Yonezawa T, Tanaka Y, Fukuyama T, Tsuchiya A, Shikata S, Iwamura H, Kinouchi C, Komatsu K, Yamasaki S, Shibata T, Sasaki AT, Schibler J, Wunderlich M, O'Brien E, Mizukawa B, Mulloy JC, Sugiura Y, Takizawa H, Shibata T, Miyake K, Kitamura T, Goyama S. IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia. EMBO Mol Med 15(1) e15631(2023) 36453131 |
Nagashima T, Ninomiya T, Nakamura Y, Nishimura S, Ohashi A, Aoki J, Mizoguchi T, Tonogi M, Takahashi T. p53 deficiency promotes bone regeneration by functional regulation of mesenchymal stromal cells and osteoblasts. J Bone Miner Metab 40(3) 434-447(2022) 35195777 |
Kanatsu-Shinohara M, Naoki H, Tanaka T, Tatehana M, Kikkawa T, Osumi N, Shinohara T. Regulation of male germline transmission patterns by the Trp53-Cdkn1a pathway. Stem Cell Reports 17(9) 1924-1941(2022) 35931081 |
Zhang P, Ohkawa Y, Yamamoto S, Momota H, Kato A, Kaneko K, Natsume A, Farhana Y, Ohmi Y, Okajima T, Bhuiyan RH, Wakabayashi T, Furukawa K, Furukawa K. St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity. Nagoya J Med Sci 83(3) 535-549(2021) 34552288 |
Kobatake K, Ikeda KI, Nakata Y, Yamasaki N, Ueda T, Kanai A, Sentani K, Sera Y, Hayashi T, Koizumi M, Miyakawa Y, Inaba T, Sotomaru Y, Kaminuma O, Ichinohe T, Honda ZI, Yasui W, Horie S, Black PC, Matsubara A, Honda H. Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction. Clin Cancer Res 26(8) 2065-2079(2020) 32047002 |
Saito Y, Chikenji TS, Matsumura T, Nakano M, Fujimiya M. Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors. Nat Commun 11(1) 889(2020) 32060352 |
Kobayashi M, Hoshino S, Abe T, Okita N, Tagawa R, Nagai W, Konno R, Suzuki Y, Furuya K, Ishikawa N, Okado H, Oku M, Iwamoto M, Miura Y, Sudo Y, Higami Y. Identification of WWP1 as an obesity-associated E3 ubiquitin ligase with a protective role against oxidative stress in adipocytes. Biochem Biophys Res Commun 508(1) 117-122(2019) 30471861 |
Mai HN, Sharma G, Sharma N, Shin EJ, Kim DJ, Pham DT, Trinh QD, Jang CG, Nah SY, Jeong JH, Kim HC. Genetic depletion of p53 attenuates cocaine-induced hepatotoxicity in mice. Biochimie 158 53-61(2019) 30576773 |
Cai W, Fujita T, Hidaka Y, Jin H, Suita K, Shigeta M, Kiyonari H, Umemura M, Yokoyama U, Sadoshima J, Ishikawa Y. Translationally controlled tumor protein (TCTP) plays a pivotal role in cardiomyocyte survival through a Bnip3-dependent mechanism. Cell Death Dis 10(8) 549(2019) 31320615 |
Sasaki H, Sugiyama M, Sasaki N. Establishment of renal proximal tubule cell lines derived from the kidney of p53 knockout mice. Cytotechnology 71(1) 45-56(2019) 30603921 |
Hayashi Y, Goyama S, Liu X, Tamura M, Asada S, Tanaka Y, Fukuyama T, Wunderlich M, O'Brien E, Mizukawa B, Yamazaki S, Matsumoto A, Yamasaki S, Shibata T, Matsuda K, Sashida G, Takizawa H, Kitamura T. Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia. Nat Commun 10(1) 4869(2019) 31653912 |
Tamura M, Yonezawa T, Liu X, Asada S, Hayashi Y, Fukuyama T, Tanaka Y, Kitamura T, Goyama S. Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms. Sci Rep 9(1) 8171(2019) 31160638 |
Saito Y, Onishi N, Takami H, Seishima R, Inoue H, Hirata Y, Kameyama K, Tsuchihashi K, Sugihara E, Uchino S, Ito K, Kawakubo H, Takeuchi H, Kitagawa Y, Saya H, Nagano O. Development of a functional thyroid model based on an organoid culture system. Biochem Biophys Res Commun 497(2) 783-789(2018) 29470983 |
Tanikawa C, Zhang YZ, Yamamoto R, Tsuda Y, Tanaka M, Funauchi Y, Mori J, Imoto S, Yamaguchi R, Nakamura Y, Miyano S, Nakagawa H, Matsuda K. The Transcriptional Landscape of p53 Signalling Pathway. EBioMedicine 20 109-119(2017) 28558959 |
Shin EJ, Nam Y, Lee JW, Nguyen PT, Yoo JE, Tran TV, Jeong JH, Jang CG, Oh YJ, Youdim MBH, Lee PH, Nabeshima T, Kim HC. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change. Mol Neurobiol 53(9) 6251-6269(2016) 26563498 |
Ohkawa Y, Momota H, Kato A, Hashimoto N, Tsuda Y, Kotani N, Honke K, Suzumura A, Furukawa K, Ohmi Y, Natsume A, Wakabayashi T, Furukawa K. Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase. J Biol Chem 290(26) 16043-58(2015) 25940087 |
Okahashi N, Kohno S, Kitajima S, Matsuda F, Takahashi C, Shimizu H. Metabolic characterization of cultured mammalian cells by mass balance analysis, tracer labeling experiments and computer-aided simulations. J Biosci Bioeng 120(6) 725-31(2015) 25936961 |
Kitajima S, Kohno S, Kondoh A, Sasaki N, Nishimoto Y, Li F, Abdallah Mohammed MS, Muranaka H, Nagatani N, Suzuki M, Kido Y, Takahashi C. Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts. Stem Cells 33(5) 1657-69(2015) 25694388 |
Okita N, Ishikawa N, Mizunoe Y, Oku M, Nagai W, Suzuki Y, Matsushima S, Mikami K, Okado H, Sasaki T, Higami Y. Inhibitory effect of p53 on mitochondrial content and function during adipogenesis. Biochem Biophys Res Commun 446(1) 91-7(2014) 24565844 |
Tochitani T, Kanemitsu H, Yamauchi H, Uchida K, Nakayama H. 5-azacytidine, a chemotherapeutic drug, induces TRAIL-mediated apoptosis in mouse thymocytes in vivo. Exp Toxicol Pathol 63(3) 237-42(2011) 20092982 |
Nam C, Doi K, Nakayama H. Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway. Histol Histopathol 25(4) 485-93(2010) 20183801 |
Tobisawa Y, Imai Y, Fukuda M, Kawashima H. Sulfation of colonic mucins by N-acetylglucosamine 6-O-sulfotransferase-2 and its protective function in experimental colitis in mice. J Biol Chem 285(9) 6750-60(2010) 20018871 |
Kawashima H. Roles of GlcNAc-6-O-sulfotransferases in lymphoid and nonlymphoid tissues. Methods Enzymol 479 243-56(2010) 20816170 |
Yamauchi H, Katayama K, Ueno M, Kanemitsu H, Nam C, Mikami T, Saito A, Ishida Y, Uetsuka K, Doi K, Ohmach Y, Nakayama H. Etoposide induces TRP53-dependent apoptosis and TRP53-independent cell cycle arrest in trophoblasts of the developing mouse placenta. Biol Reprod 80(4) 813-22(2009) 19109225 |
Kanemitsu H, Yamauchi H, Komatsu M, Yamamoto S, Okazaki S, Uchida K, Nakayama H. 6-mercaptopurine (6-MP) induces p53-mediated apoptosis of neural progenitor cells in the developing fetal rodent brain. Neurotoxicol Teratol 31(4) 198-202(2009) 19281843 |